Industry

‘VecTabs’ developed using VectorY’s proprietary platform show positive effect on key drivers of ALS pathology AMSTERDAM–(BUSINESS WIRE)–VectorY, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neurodegenerative and muscular disorders through vectorized antibodies, today announced new data at the 2022 ENCALS meeting in Edinburgh. The poster, which was … [Read more…]

– Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership … [Read more…]

Kai.ai longitudinal and retrospective studies are accepted for publication in the Journal of Medical Internet Research for peer review NEW YORK–(BUSINESS WIRE)–#mentalhealth—Kai.ai, the market leader in AI-based technology for mental health and well-being care to adolescents, has announced that two of its research papers have been accepted for publication by The Journal of Medical Internet … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Glucose Biosensors Market Size, Share & Trends Analysis Report by Type (Electrochemical, Optical, Others), by End Use (Hospitals, Homecare, Diagnostic centers), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global glucose biosensor market size is expected to reach USD 20.1 billion by 2030. The market is expected … [Read more…]

100% of millennials achieved greater than 1-point improvement on the Glabellar Line Scale on days 7, 14 and 30 100% of millennials were satisfied or very satisfied with treatment on days 7 and 30 Jeuveau® found to be well-tolerated by both millennials and non-millennials NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence-enabled Drug Discovery, 2022: Frost Radar Report” report has been added to ResearchAndMarkets.com’s offering. This report presents competitive profiles on each of the companies based on their strengths, opportunities, and a small discussion on their positioning. The report finds that the impact of AI on the entire pharma value chain can more … [Read more…]

LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that the Company will present at the Jefferies Healthcare Conference on Thursday, June 9th at 10:00 a.m. … [Read more…]

Live webcast of Spatial Multiomic Symposium on Monday, June 6, from noon to 4 pm EDT Data from twenty scientific studies highlight the use of NanoString’s spatial biology platforms SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ … [Read more…]

Clinical-stage program UPB-101 targets the TSLP receptor, a cytokine receptor positioned upstream in the inflammatory cascade with the potential to impact multiple diseases, including asthma Pipeline growth strategy includes pursuing UPB-101 in multiple diseases and acquiring additional drug candidates Aaron Deykin, MD, appointed as Chief Medical Officer and Head of Research and Development WALTHAM, Mass.–(BUSINESS … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Non-Alcoholic Steatohepatitis Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel” report has been added to ResearchAndMarkets.com’s offering. The global non-alcoholic steatohepatitis (NASH) market is projected to reach US$ 24,266.81 million by 2028 from US$ 1,631.92 million in 2021; it is expected to grow at … [Read more…]